Status epilepticus

3 trials 2 recruiting MedDRA PT
3 Registered trials
2 Recruiting
3 Unique sponsors
9 Unique IMPs
1 Commercial trials
Drug classes (ATC)
N Neurology/Psychiatry (ATC N) 2
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 7 substances
Benzodiazepine 2 substances
Phase III: 2 Phase IV: 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase III

2 trials
  • Marinus Pharmaceuticals Inc. Commercial
    GANAXOLONE
    2022-502540-12-00 14 countries 2023 n=66
    Ended
  • Universiteit Twente Academic
    DIAZEPAM; ESKETAMINE; LACOSAMIDE; LEVETIRACETAM; LORAZEPAM; MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE; PROPOFOL; SODIUM VALPROATE
    2024-516068-27-01 2 countries 2025 n=150
    Recruiting

Phase IV

1 trial
  • Universitaet Leipzig Academic
    IMP not specified
    2024-516634-35-00 1 country 2024 n=132
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Marinus Pharmaceuticals Inc. Commercial 1 Phase III 0
Universiteit Twente Academic 1 Phase III 1
Universitaet Leipzig Academic 1 Phase IV 1
New trials by year
2023
1
2024
1
2025
1
← All indication landscapes